Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Thomas Ringgaard Petersen, Vasiliki Panou, Christos Meristoudis, Ulla Møller Weinreich & Oluf Dimitri Røe. (2021) Clinical prognostic factors in pleural mesothelioma: best supportive care and anti-tumor treatments in a real-life setting. Acta Oncologica 60:4, pages 521-527.
Read now
Read now
Yasuhiro Nakajima, Kozo Kuribayashi, Hirotoshi Ishigaki, Akio Tada, Yoshiki Negi, Toshiyuki Minami, Ryo Takahashi, Hiroshi Doi, Kazuhiro Kitajima, Takashi Yokoi & Takashi Kijima. (2020) Adenosine Deaminase in Pleural Effusion and Its Relationship with Clinical Parameters in Patients with Malignant Pleural Mesothelioma. Cancer Investigation 38:6, pages 356-364.
Read now
Read now
Articles from other publishers (41)
Seiki Hasegawa, Yasushi Shintani, Teruhisa Takuwa, Keisuke Aoe, Katsuya Kato, Nobukazu Fujimoto, Yasuhiro Hida, Masahiro Morise, Yasumitsu Moriya, Takao Morohoshi, Hidemi Suzuki, Masayuki Chida, Shunsuke Endo, Mitsutaka Kadokura, Meinoshin Okumura, Satoshi Hattori, Hiroshi Date & Ichiro Yoshino. (2023) Nationwide prospective registry database of patients with newly diagnosed untreated pleural mesothelioma in Japan. Cancer Science.
Crossref
Crossref
Luka Brcic, Nolwenn Le Stang, Florian Gallob, Daniel Pissaloux, Ruth Sequeiros, Sandrine Paindavoine, Jean Claude Pairon, Marie Karanian, Sanja Dacic, Nicolas Girard, Andrew Churg, Franck Tirode & Francoise Galateau-Salle. (2023)
A Combination of MTAP and p16 Immunohistochemistry Can Substitute for
CDKN2A
Fluorescence In Situ Hybridization in Diagnosis and Prognosis of Pleural Mesotheliomas
. Archives of Pathology & Laboratory Medicine 147:3, pages 313-322.
Crossref
Crossref
Dandan Gong, Jian Yu & Xiaodong Jiang. (2022) Case report: Rare intrapulmonary malignant mesothelioma complicated with myositis. Frontiers in Oncology 12.
Crossref
Crossref
Shengteng Shao, Lei Sun, Kun Qin, Xiangfeng Jin, Tengfei Yi, Yuhong Liu & Yuanyong Wang. (2022) Survival analysis and development of a prognostic nomogram for patients with malignant mesothelioma in different anatomic sites. Frontiers in Oncology 12.
Crossref
Crossref
Yasuko Nagamatsu, Yumi Sakyo, Edward Barroga, Riwa Koni, Yuji Natori & Mitsunori Miyashita. (2022) Depression and Complicated Grief, and Associated Factors, of Bereaved Family Members of Patients Who Died of Malignant Pleural Mesothelioma in Japan. Journal of Clinical Medicine 11:12, pages 3380.
Crossref
Crossref
Philipp Jurmeister, Maximilian Leitheiser, Peggy Wolkenstein, Frederick Klauschen, David Capper & Luka Brcic. (2022) DNA methylation-based machine learning classification distinguishes pleural mesothelioma from chronic pleuritis, pleural carcinosis, and pleomorphic lung carcinomas. Lung Cancer.
Crossref
Crossref
Melih ŞİMŞEK, Ulaş IŞIK & Orkun GÜRBÜZ. (2022) Malign mezotelyomada kemoterapi uygulamalarıChemotherapy applications in malign mesothelioma. Ege Tıp Dergisi 61:1, pages 15-21.
Crossref
Crossref
Yosuke Miyamoto, Toshiyuki Kozuki, Keisuke Aoe, Sae Wada, Daijiro Harada, Michihiro Yoshida, Jun Sakurai, Katsuyuki Hotta & Nobukazu Fujimoto. (2021) JME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma. Journal for ImmunoTherapy of Cancer 9:10, pages e003288.
Crossref
Crossref
Nobukazu Fujimoto, Morihito Okada, Takashi Kijima, Keisuke Aoe, Terufumi Kato, Kazuhiko Nakagawa, Yuichiro Takeda, Toyoaki Hida, Kuninobu Kanai, Jun Hirano & Yuichiro Ohe. (2021) Clinical Efficacy and Safety of Nivolumab in Japanese Patients With Malignant Pleural Mesothelioma: 3-Year Results of the MERIT Study. JTO Clinical and Research Reports 2:3, pages 100135.
Crossref
Crossref
Yasuko Nagamatsu. 2021. Malignant Pleural Mesothelioma. Malignant Pleural Mesothelioma
233
240
.
Zhaoqiang Jiang, Wei Shen, Shibo Ying, Zhibin Gao, Xianglei He, Riping Chen, Hailing Xia, Xinnian Guo, Yuan Fang, Yixiao Zhang, Jianjiang Miao, Jian Zhou, Xing Zhang, Junqiang Chen & Jianlin Lou. (2020) Overexpression of fibulin-3 in tumor tissue predicts poor survival of malignant mesothelioma patients from hand-spinning asbestos exposed area in eastern China. Scientific Reports 10:1.
Crossref
Crossref
Yuka Ide, Tsunetsugu Yuki, Yasuyuki Taooka, Yusuke Higashi & Yoshiro Tachiyama. (2020) Malignant Peritoneal Mesothelioma Presenting with Polymyalgia Rheumatica-like Syndrome. Internal Medicine 59:20, pages 2629-2632.
Crossref
Crossref
Yasumasa Okazaki, Shan Hwu Chew, Hirotaka Nagai, Yoriko Yamashita, Hiroki Ohara, Li Jiang, Shinya Akatsuka, Takashi Takahashi & Shinya Toyokuni. (2020) Overexpression of miR‐199/214 is a distinctive feature of iron‐induced and asbestos‐induced sarcomatoid mesothelioma in rats. Cancer Science 111:6, pages 2016-2027.
Crossref
Crossref
Dareen AbdE Mohamed & AlaaI Amer. (2020) The promising role of mucin 4 in association with D2-40 immunohistochemistry in differentiating pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma. Egyptian Journal of Pathology 40:2, pages 237.
Crossref
Crossref
Morihito Okada, Takashi Kijima, Keisuke Aoe, Terufumi Kato, Nobukazu Fujimoto, Kazuhiko Nakagawa, Yuichiro Takeda, Toyoaki Hida, Kuninobu Kanai, Fumio Imamura, Satoshi Oizumi, Toshiaki Takahashi, Mitsuhiro Takenoyama, Hiroshi Tanaka, Jun Hirano, Yoshinobu Namba & Yuichiro Ohe. (2019)
Clinical Efficacy and Safety of Nivolumab: Results of a
M
ulticenter, Op
e
n-label, Single-a
r
m, Japanese Phase II study in Mal
i
gnant Pleural Meso
t
helioma (MERIT)
. Clinical Cancer Research 25:18, pages 5485-5492.
Crossref
Crossref
Maki Ohya, Mikiko Kobayashi, Toshiro Sozuki, Hiroyuki Kanno & Koh Nakazawa. (2019) Malignant peritoneal mesothelioma diagnosed 50�years post‑radiotherapy for ovarian cancer in a patient with a history of multiple malignancies: An autopsy case. Molecular and Clinical Oncology.
Crossref
Crossref
Anna C. Bibby, Duneesha de Fonseka, David J. Carslake & Nick A. Maskell. (2019) Is pleural infection associated with longer survival in mesothelioma? A population-based cohort study using data from Hospital Episode Statistics. Cancer Epidemiology 59, pages 75-82.
Crossref
Crossref
Article Editorial. (2019) Clinical guidelines on diagnosis and management of patientsа with malignant pleural mesothelioma (рart 2). Russian Pulmonology 28:6, pages 655-679.
Crossref
Crossref
Ting-Hui Wu, Lukas Jyuhn-Hsiarn Lee, Chang-Tsu Yuan, Tom Wei-Wu Chen & James Chih-Hsin Yang. (2019) Prognostic factors and treatment outcomes of malignant pleural mesothelioma in Eastern Asian patients – A Taiwanese study. Journal of the Formosan Medical Association 118:1, pages 230-236.
Crossref
Crossref
Article Editorial. (2018) Clinical guidelines on diagnosis and management of patients with malignant pleural mesothelioma (part 1). Russian Pulmonology 28:5, pages 531-557.
Crossref
Crossref
Daoshan Zheng, Cecilia Williams, Jeremy A. Vold, Justin H. Nguyen, Denise M. Harnois, Sanjay P. Bagaria, Sarah A. McLaughlin & Zhaoyu Li. (2018) Regulation of sex hormone receptors in sexual dimorphism of human cancers. Cancer Letters 438, pages 24-31.
Crossref
Crossref
Nobukazu Fujimoto, Keisuke Aoe, Toshiyuki Kozuki, Isao Oze, Katsuya Kato, Takumi Kishimoto & Katsuyuki Hotta. (2018) A Phase II Trial of First-Line Combination Chemotherapy With Cisplatin, Pemetrexed, and Nivolumab for Unresectable Malignant Pleural Mesothelioma: A Study Protocol. Clinical Lung Cancer 19:5, pages e705-e707.
Crossref
Crossref
Katsuya Kato, Kenichi Gemba, Kazuto Ashizawa, Hiroaki Arakawa, Satoshi Honda, Naomi Noguchi, Sumihisa Honda, Nobukazu Fujimoto & Takumi Kishimoto. (2018) Low-dose chest computed tomography screening of subjects exposed to asbestos. European Journal of Radiology 101, pages 124-128.
Crossref
Crossref
Ian Woolhouse, Lesley Bishop, Liz Darlison, Duneesha De Fonseka, Anthony Edey, John Edwards, Corinne Faivre-Finn, Dean A Fennell, Steve Holmes, Keith M Kerr, Apostolos Nakas, Tim Peel, Najib M Rahman, Mark Slade, Jeremy Steele, Selina Tsim & Nick A Maskell. (2018) British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma. Thorax 73:Suppl 1, pages i1-i30.
Crossref
Crossref
Shofu Matsuda, Eri Nakajima, Takuya Nakanishi, Airi Hitsuji, Hong Zhang, Akane Tanaka, Hiroshi Matsuda, Toshiyuki Momma & Tetsuya Osaka. (2017) Effective induction of death in mesothelioma cells with magnetite nanoparticles under an alternating magnetic field. Materials Science and Engineering: C 81, pages 90-96.
Crossref
Crossref
Wataru Shigeeda, Masahiko Shibazaki, Shinji Yasuhira, Tomoyuki Masuda, Tatsuo Tanita, Yuka Kaneko, Tatsuhiro Sato, Yoshitaka Sekido & Chihaya Maesawa. (2017) Hyaluronic acid enhances cell migration and invasion via the YAP1/TAZ-RHAMM axis in malignant pleural mesothelioma. Oncotarget 8:55, pages 93729-93740.
Crossref
Crossref
Li-Ming Wang, Zhen-Wang Shi, Ji-Ling Wang, Zhi Lv, Fang-Bin Du, Qing-Bin Yang & Yong Wang. (2017) Diagnostic accuracy of BRCA1-associated protein 1 in malignant mesothelioma: a meta-analysis. Oncotarget 8:40, pages 68863-68872.
Crossref
Crossref
Kei Kushitani, Vishwa J Amatya, Yasuko Okada, Yuya Katayama, Amany S Mawas, Yoshihiro Miyata, Morihito Okada, Kouki Inai, Takumi Kishimoto & Yukio Takeshima. (2017) Utility and pitfalls of immunohistochemistry in the differential diagnosis between epithelioid mesothelioma and poorly differentiated lung squamous cell carcinoma. Histopathology 70:3, pages 375-384.
Crossref
Crossref
Tomoyuki Hida, Makoto Hamasaki, Shinji Matsumoto, Ayuko Sato, Tohru Tsujimura, Kunimitsu Kawahara, Akinori Iwasaki, Tatsuro Okamoto, Yoshinao Oda, Hiroshi Honda & Kazuki Nabeshima. (2017) Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry. Lung Cancer 104, pages 98-105.
Crossref
Crossref
Robert Shavelle, Kate Vavra-Musser, Jessica Lee & Jordan Brooks. (2017) Life Expectancy in Pleural and Peritoneal Mesothelioma. Lung Cancer International 2017, pages 1-8.
Crossref
Crossref
Tomoyuki Hida, Makoto Hamasaki, Shinji Matsumoto, Ayuko Sato, Tohru Tsujimura, Kunimitsu Kawahara, Akinori Iwasaki, Tatsuro Okamoto, Yoshinao Oda, Hiroshi Honda & Kazuki Nabeshima. (2016)
BAP1 immunohistochemistry and
p16
FISH results in combination provide higher confidence in malignant pleural mesothelioma diagnosis: ROC analysis of the two tests
. Pathology International 66:10, pages 563-570.
Crossref
Crossref
Katsuya Kato, Kenichi Gemba, Nobukazu Fujimoto, Keisuke Aoe, Yukio Takeshima, Kouki Inai & Takumi Kishimoto. (2016) Pleural irregularities and mediastinal pleural involvement in early stages of malignant pleural mesothelioma and benign asbestos pleural effusion. European Journal of Radiology 85:9, pages 1594-1600.
Crossref
Crossref
Katsuya Kato, Kenichi Gemba, Nobukazu Fujimoto, Keisuke Aoe, Yukio Takeshima, Kouki Inai & Takumi Kishimoto. (2016) Fatal pleural mesothelioma in Japan (2003–2008): evaluation of computed tomography findings. Japanese Journal of Radiology 34:6, pages 432-438.
Crossref
Crossref
James Benjamin Gleason, Basheer Tashtoush & Maria Julia Diacovo. (2016) Biphasic Malignant Pleural Mesothelioma Masquerading as a Primary Skeletal Tumor. Case Reports in Pulmonology 2016, pages 1-5.
Crossref
Crossref
R.A. Damhuis, A. Khakwani, H. De Schutter, A.L. Rich, J.A. Burgers & J.P. van Meerbeeck. (2015) Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and England. Lung Cancer 89:2, pages 212-217.
Crossref
Crossref
Tomoyuki Hida, Makoto Hamasaki, Shinji Matsumoto, Sosei Abe, Koji Takakura, Kenzo Hiroshima & Kazuki Nabeshima. (2015) Diffuse intrapulmonary malignant mesothelioma presenting with miliary pulmonary nodules: A case report. Pathology International 65:6, pages 318-323.
Crossref
Crossref
Yuki Kataoka, Yosuke Yamamoto, Taiichiro Otsuki, Mariko Shinomiya, Takayuki Terada, Shingo Fukuma, Shin Yamazaki, Masataka Hirabayashi, Takashi Nakano & Shunichi Fukuhara. (2015) A new prognostic index for overall survival in malignant pleural mesothelioma: the rPHS (regimen, PS, histology or stage) index. Japanese Journal of Clinical Oncology 45:6, pages 562-568.
Crossref
Crossref
Nobukazu Fujimoto, Kei Ohnuma, Keisuke Aoe, Osamu Hosono, Taketo Yamada, Takumi Kishimoto & Chikao Morimoto. (2014) Clinical Significance of Soluble CD26 in Malignant Pleural Mesothelioma. PLoS ONE 9:12, pages e115647.
Crossref
Crossref
Go Makimoto, Keiichi Fujiwara, Nobukazu Fujimoto, Ichiro Yamadori, Toshio Sato & Takumi Kishimoto. (2014) Phrenic Nerve Paralysis as the Initial Presentation in Pleural Sarcomatoid Mesothelioma. Case Reports in Oncology 7:2, pages 389-392.
Crossref
Crossref
Nobukazu Fujimoto, Keisuke Aoe, Satoshi Oizumi, Toshiyuki Kozuki, Toshiaki Kamei, Hirotaro Miura, Kouki Inai & Takumi Kishimoto. (2014) Clinical Investigation of Hyaluronic Acid in Pleural Effusion. Haigan 54:6, pages 767-771.
Crossref
Crossref
Zhou-Hong Yao, Guang-Yan Tian, Yun-Yan Wan, Yan-Meng Kang, Hai-Sheng Guo, Qing-Hua Liu & Dian-Jie Lin. (2013) Prognostic nutritional index predicts outcomes of malignant pleural mesothelioma. Journal of Cancer Research and Clinical Oncology 139:12, pages 2117-2123.
Crossref
Crossref